IGFBP2 and neoplasm: Tumor xenograft experiments were conducted using HepG2 cells with IGFBP2 overexpression and with vector control, and the results showed enhanced tumor progression in the group with IGFBP2 overexpression compared with the control group, as evidenced by the increased tumor weight and volume (Fig. 4A–C).